Albertsons (ACI) Q4 FY26 earnings call

Albertsons reported its Q4 FY25 results, delivering better-than-expected adjusted EBITDA and strong shareholder returns, navigating significant pharmacy headwinds and consumer pressure through operational agility and productivity. The company is confident in its FY26 outlook, driven by a $2 billion 3-year productivity program, AI-enabled initiatives, and continued investment in its differentiated growth model focused on personalization and balanced value.